Pharmacognosy in the New Millennium: Leadfinding and Biotechnology

In the past hundred years, synthetic drugs had gradually replaced plant-derived drugs, except for antibiotics and antitumor drugs. Due ; ; to the development of experimentation with molecules, new openings and perspectives appear for natural products. Progress in bio\ i technology, biochemistry and research on metabolism are also the cause of renewed interest in natural resources. j » This interest is based on growing awareness that a large number of secondary metabolites playing a significant role for the prevention ; [ of diseases are also present in our food. The food-processing industry is heavily investing in this branch, which results in an improve,' ment of the overall quality of our diet, including the development of functional food and neutraceuticals. ,

[1]  J. Memelink,et al.  Molecular Cloning and Analysis of Strictosidine β-d-Glucosidase, an Enzyme in Terpenoid Indole Alkaloid Biosynthesis in Catharanthus roseus * , 2000, The Journal of Biological Chemistry.

[2]  R. Verpoorte,et al.  Chapter 13 – Salicylic acid biosynthesis , 1999 .

[3]  C. Méndez,et al.  Genetic manipulation of antitumor-agent biosynthesis to produce novel drugs. , 1998, Trends in biotechnology.

[4]  G. Pasquali,et al.  Effects of over-expression of strictosidine synthase and tryptophan decarboxylase on alkaloid production by cell cultures of Catharanthus roseus , 1998, Planta.

[5]  E. Grotewold,et al.  Engineering Secondary Metabolism in Maize Cells by Ectopic Expression of Transcription Factors , 1998, Plant Cell.

[6]  T. A. Beek,et al.  Distribution of ginkgolides and terpenoid biosynthetic activity in Ginkgo biloba , 1998 .

[7]  R. Verpoorte.  Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development , 1998 .

[8]  J. Howard,et al.  Production of recombinant proteins in transgenic plants: Practical considerations , 1997, Biotechnology and bioengineering.

[9]  J. van der Greef,et al.  Theoretical concepts of on-line liquid chromatographic-biochemical detection systems. I. Detection systems based on labelled ligands. , 1997, Journal of chromatography. A.

[10]  G. Pasquali,et al.  Suspension cultured transgenic cells of Nicotiana tabacum expressing tryptophan decarboxylase and strictosidine synthase cDNAs from Catharanthus roseus produce strictosidine upon secologanin feeding , 1997, Plant Cell Reports.

[11]  A. J. Oosterkamp,et al.  Novel monitoring strategies for xenoestrogens , 1997 .

[12]  Joseph C. Hogan,et al.  Combinatorial chemistry in drug discovery , 1997, Nature Biotechnology.

[13]  C. Arntzen.  High-tech herbal medicine: Plant-based vaccines , 1997, Nature Biotechnology.

[14]  D J Newman,et al.  Natural products in drug discovery and development. , 1997, Journal of natural products.

[15]  G. Whitelam,et al.  Antibody expression in transgenic plants , 1996 .

[16]  A. Ponstein,et al.  Production of Enzymes for Industrial Use , 1996 .

[17]  J. Ma,et al.  Antibody Production and Engineering in Plants , 1996, Annals of the New York Academy of Sciences.

[18]  Cathie Martin.  Transcription factors and the manipulation of plant traits , 1996 .

[19]  Mahabir P. Gupta,et al.  Natural product drug discovery and development: new perspectives on international collaboration. , 1995, Journal of natural products.

[20]  J. L. Gittleman,et al.  The Future of Biodiversity , 1995, Science.

[21]  T. Kutchan,et al.  Alkaloid Biosynthesis[mdash]The Basis for Metabolic Engineering of Medicinal Plants. , 1995, The Plant cell.

[22]  David G. Corley,et al.  Strategies for Database Dereplication of Natural Products , 1994 .

[23]  and T Hashimoto,et al.  Alkaloid Biogenesis: Molecular Aspects , 1994 .

[24]  N. Brisson,et al.  Redirection of tryptophan leads to production of low indole glucosinolate canola. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Verpoorte,et al.  Terpenoid indole alkaloid biotransformation capacity of suspension cultures of Tabernaemontana divaricata , 1994 .

[26]  R. Verpoorte,et al.  Ajmalicine metabolism in Catharanthus roseus cell cultures , 1994 .

[27]  R. Verpoorte,et al.  PLANT CELL BIOTECHNOLOGY FOR THE PRODUCTION OF ALKALOIDS: PRESENT STATUS AND PROSPECTS' , 1993 .

[28]  J. Heijnen,et al.  Scaleup of ajmalicine production by plant cell cultures of Catharanthus roseus , 1993, Biotechnology and bioengineering.

[29]  H. Kindl,et al.  Disease resistance results from foreign phytoalexin expression in a novel plant , 1993, Nature.

[30]  Y. Yamada,et al.  Metabolic engineering of medicinal plants: transgenic Atropa belladonna with an improved alkaloid composition. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Ronald W. Davis,et al.  Arabidopsis and Nicotiana anthocyanin production activated by maize regulators R and C1. , 1992, Science.

[32]  R. Verpoorte,et al.  Developmental regulation of alkaloid production in Cinchona seedlings. , 1990 .

[33]  H. Blanch,et al.  Economic assessment of plant cell culture for the production of ajmalicine , 1987, Biotechnology and bioengineering.

[34]  Gadamer.  Handbuch der Pharmakognosie. Von A. Tschirch. Dritter Band, erste Abteilung. Mit 189 Abb. im Text, 13 Tafeln, 1 Karte u. 1 Tab. Leipzig 1923. Verlag Ch. H. Tauchnitz , 1924 .

[35]  R. Verpoorte,et al.  Metabolic Engineering of Plant Secondary Metabolism , 2000, Springer Netherlands.

[36]  Ronald J. Quinn,et al.  QPRI’s System for Screening of Natural Products , 1999 .

[37]  Lars Bohlin,et al.  Bioassay methods in natural product research and drug development : proceedings of the international symposium on Bioassay Methods in Natural Product Research and Drug Development, held at the Biomedical Centre of Uppsala University, Sweden, from 24-27 August 1997 , 1999 .

[38]  R. Verpoorte.  Chemodiversity and the Biological Role of Secondary Metabolites, Some Thoughts for Selecting Plant Material for Drug Development , 1999 .

[39]  F. Shahidi,et al.  Chemicals via Higher Plant Bioengineering , 1999, Advances in Experimental Medicine and Biology.

[40]  Wayne R. Curtis,et al.  Plant Cell and Tissue Culture for the Production of Food Ingredients , 1999, Springer US.

[41]  D. Macneil,et al.  Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius , 1998, Nature Biotechnology.

[42]  J. Memelink,et al.  Chapter 12 Plant Biotechnology and the Production of Alkaloids: Prospects of Metabolic Engineering , 1998 .

[43]  C. Cunningham,et al.  Recombinant proteins from plants : production and isolation of clinically useful compounds , 1998 .

[44]  R. Shepherd,et al.  Engineering plants for commercial products and applications , 1996 .

[45]  R. Griffin,et al.  Organic reactivity : physical and biological aspects , 1995 .

[46]  A. Hiatt,et al.  Protein production in transgenic crops: analysis of plant molecular farming. , 1993 .

[47]  R. Verpoorte,et al.  Control and biological implications of alkaloid synthesis inCinchona seedlings , 1991 .

[48]  M. Zenk.  6. Chasing the enzymes of secondary metabolism: Plant cell cultures as a pot of gold , 1991 .

[49]  K. Westphal.  Large-Scale Production of New Biologically Active Compounds in Plant-Cell Cultures , 1990 .

[50]  M. N. Zaprometov.  Proanthocyanidins and Catechins , 1988 .

[51]  M. N. Zaprometov.  Tannins, Lignans, and Lignins , 1988 .

[52]  M. Tabata,et al.  Secondary metabolites from plant cells: pharmaceutical applications and progress in commercial production , 1986 .

[53]  Yasuyuki Yamada,et al.  High berberine-producing cultures of Coptis japonica cells , 1984 .

[54]  Professor Dr. Martin Luckner.  Secondary Metabolism in Microorganisms, Plants and Animals , 1984, Springer Berlin Heidelberg.

[55]  E. J. Staba,et al.  Plant tissue culture as a source of biochemicals , 1980 .

[56]  J. Harborne.  Biochemical aspects of plant and animal coevolution. , 1978 .

[57]  A. Tschirch,et al.  Handbuch der Pharmakognosie , 1921, Nature.